scorpion eli lilly news - Search News

Eli Lilly in talks to acquire Scorpion Therapeutics, FT says

Seeking Alpha on MSN · 18h

Eli Lilly in talks to acquire Scorpion Therapeutics, FT says; Relay Therapeutics seesaws

Eli Lilly (NYSE:LLY) is in advanced discussions to purchase cancer-focused biotech Scorpion Therapeutics for as much as $2.5 billion. Eli Lilly (NYSE:LLY) is expected to pay around $1 billion upfront for the privately owned Scorpion,

The Financial Times · 12h

Eli Lilly in advanced talks to buy US cancer biotech for up to $2.5bn

Scorpion’s drug candidate inhibits a mutation that is a major driver of breast, gynaecological and head and neck cancers

Business Insider · 18h

Lilly in advanced talks to buy cancer biotech Scorpion for up to $2.5B, FT says

Eli Lilly (LLY) is in advanced talks to buy cancer-focused biotech Scorpion Therapeutics in a deal worth up to $2.5B, people close to the talks

1h

Eli Lilly: Still Expensive As Earnings Near, But Not Worthy Of A Downgrade

Financial writer cautious on Eli Lilly stock despite strong performance, citing high valuation and underperforming drugs.

5d

Eli Lilly & Co.: Strategic Growth Driven by Mounjaro and Zepbound with Attractive Entry Point

Chris Schott, an analyst from J.P. Morgan, maintained the Buy rating on Eli Lilly & Co (LLY – Research Report). The associated price target ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results